Tulane’s efforts to treat, cure and prevent disease are not confined within the walls of the School of Medicine. Instead, the most exciting medical discoveries will happen across campuses and departments made possible by the teamwork of researchers in multiple schools and departments. Three School of Medicine investigators one who recently joined Tulane, one who has seven years of service to the university, and one who returned to Tulane shortly before the pandemic began show that the future of medicine hinges on capacity for collaboration, inside the lab and out.
GIOVANNI PIEDIMONTE, MD
Giovanni Piedimonte, MD, has always espoused a collaborative approach. Piedimonte, a practicing pediatric pulmonary physician, investigator and administrator who joined Tulane as vice president for research and institutional official, as well as a professor in the Department of Pediatrics, keeps an eye toward the evolution of medicine and physician education.
LEXINGTON, Ky. (May 6, 2021) The University of Kentucky Board of Trustees has approved honorary degrees for four citizens who have distinguished themselves in their careers and community service. The recipients are W. Harry Clarke, F. Joseph Halcomb III, Deirdre Lyons and Carl F. Pollard.
Clarke, Halcomb and Lyons will receive their honorary doctorates at the UK May 2021 Commencement Ceremonies next week. Pollard, who is unable to attend next week s ceremonies, will be honored at a later date.
Honorary degrees will be presented at the following ceremonies:
W. Harry Clarke: noon Friday, May 14
F. Joseph Halcomb: 6 p.m. Friday, May 14
Deirdre Lyons: noon Sunday, May 16
Длительный сон отнесли к признакам болезни rg.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rg.ru Daily Mail and Mail on Sunday newspapers.
Novel cryomicroneedle patch successfully delivers therapeutic cells in mice
SHARES
A cryomicroneedle patch ready for deployment [Credit: Chang et al. /DOI number: 10.1038/s41551-021-00720-1].
In a pre-clinical proof-of-concept study, cellular cancer immunotherapy delivered via the cryomicroneedle patch was found to be more effective than the same cells delivered by intravenous and subcutaneous injections.
In the study, led by Dr Xu Chenjie, Associate Professor at the Department of Biomedical Engineering (BME) at the City University of Hong Kong (CityU) and published in
Nature Biomedical Engineering, the team demonstrated that using their cryomicroneedle technology to vaccinate mice with ovalbumin-pulsed dendritic cells elicited robust immune responses against subcutaneous melanoma tumours.